강진형

교수
    

  #폐암#두경부암#흑색종

학력

1978~1984
가톨릭대학교 의학 학사
1986~1988
가톨릭대학교 내과학 석사
1991~1995
가톨릭대학교 내과학 박사

경력

2011~2015
서울성모병원 임상분과장
2007~2009
강남성모병원 임상분과장
2006~2016
강남성모병원 학과장
1991~1993
강남성모병원 내과 임상강사
1985~1988
성모병원 내과 레지던트
1984~1985
성모병원 인턴

논문

2020 Nov
CANCERS 교신저자
A Highly Sensitive Next-Generation Sequencing-Based Genotyping Platform for EGFR Mutations in Plasma from Non-Small Cell Lung Cancer Patients

2020 Nov
BMC CANCER 교신저자
Anti-tumor efficacy of CKD-516 in combination with radiation in xenograft mouse model of lung squamous cell carcinoma

2020 Oct
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 공동저자
Two-year follow-up of a randomized phaseIIIclinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate141)

2020 Jul
CANCER RESEARCH AND TREATMENT 제1저자
Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting

2020 Jun
KOREAN JOURNAL OF CLINICAL ONCOLOGY(대한종양외과학회지) 교신저자
Clinical experience of immune checkpoint inhibitor for a metastatic jejunal cancer patient with a high tumor mutational burden and low expression of programmed death-ligand 1

2020 Apr
CLINICAL & EXPERIMENTAL METASTASIS 공동저자
Upfront radiosurgery plus targeted agents followed by active brain control using radiosurgery delays neurological death in non-small cell lung cancer with brain metastasis

2020 Apr
CANCERS 교신저자
Evaluation of Two EGFR Mutation Tests on Tumor and Plasma from Patients with Non-Small Cell Lung Cancer

2020 Mar
CURRENT MEDICAL RESEARCH AND OPINION 공동저자
Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis

2020 Feb
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 교신저자
Prognostic value of 18F-FDG PET parameters in patientswith locally advanced non-small cell lung cancer treatedwith induction chemotherapy

2020 Jan
JOURNAL OF THORACIC ONCOLOGY 공동저자
A Randomized Phase 2 Study of Gefitinib With or Without Pemetrexed as First-line Treatment in Nonsquamous NSCLC With EGFR Mutation: Final Overall Survival and Biomarker Analysis
2020 Jan
CANCER RESEARCH AND TREATMENT 공동저자
Osimertinib in Patients with T790M-Positive Advanced Non-small Cell Lung Cancer: Korean Subgroup Analysis from Phase II Studies

2018 Oct
TUBERCULOSIS AND RESPIRATORY DISEASES(결핵 및 호흡기질환) 공동저자
Clinical Characteristics of False-Positive Lymph Node on Chest CT or PET-CT Confirmed by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in Lung Cancer

2018 Oct
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 교신저자
Efficacy and safety of oxycodone/naloxone as add-on therapy to gabapentin or pregabalin for the management of chemotherapy-induced peripheral neuropathy in Korea

2018 Sep
CANCER SCIENCE 공동저자
Clinical activity of ASP8273 in Asian patients with non-small-cell lung cancer with EGFR activating and T790M mutations

2018 Aug
LUNG CANCER 공동저자
Nivolumab in advanced non-small-cell lung cancer patients who failed prior platinum-based chemotherapy

2018 Aug
JOURNAL OF NEURO-ONCOLOGY 공동저자
Intracranial control and survival outcome of tyrosine kinase inhibitor (TKI) alone versus TKI plus radiotherapy for brain metastasis of epidermal growth factor receptor-mutant non-small cell lung cancer

2018 Jul
KOREAN JOURNAL OF INTERNAL MEDICINE 공동저자
Radiation nephritis: 99mTc hydroxydiphosphonate bone scan, 99mTc dimercaptosuccinic acid renal scan, and 18F-FDG PET/CT findings

2018 Jul
SUPPORTIVE CARE IN CANCER 공동저자
Patient and oncologist perceptions regarding symptoms and impact on quality-of-life of oral mucositis in cancer treatment: results from the Awareness Drives Oral Mucositis PercepTion (ADOPT) study

2018 Mar
SURGICAL ONCOLOGY-OXFORD 교신저자
Detection of RET (rearranged during transfection) variants and their downstream signal molecules in RET rearranged lung adenocarcinoma patients

2018 Mar
PATHOLOGY RESEARCH AND PRACTICE 공동저자
Overexpression of YAP1 in EGFR mutant lung adenocarcinoma prior to tyrosine kinase inhibitor therapy is associated with poor survival

2018 Feb
ONCOLOGIST 공동저자
Phase I Pharmacokinetic Study of Nivolumab in Korean Patients with Advanced Solid Tumors

2017 Jun
KOREAN SOCIETY OF INFECTIOUS DISEASES 교신저자
Henoch-Schonlein Purpura with Concurrent Cytomegalovirus Duodenitis

2016 Oct
CANCER RESEARCH AND TREATMENT 공동저자
Predicto

저서

2016 Dec
도서출판 진기획 공동
폐암 무엇이든 물어보세요

보도자료

정밀의학과 임상시험
http://news.chosun.com/site/data/html_dir/2019/05/19/2019051901182.html

[기고] 웰니스 추구하는 소비자… 의료계도 단순한 통증 치료에서 벗어나야
http://news.chosun.com/site/data/html_dir/2019/04/23/2019042301875.html

면역항암제가 암의 만병통치약? 효과 보는 환자 30%에 불과
http://health.chosun.com/site/data/html_dir/2018/04/17/2018041700154.html

"폐암치료제 '타그리소', 재발없이 생존기간 2배 연장"
https://www.yna.co.kr/view/AKR20171213093900017

백혈병 개별 맞춤형 유전자 치료제 시대 돌입…FDA 첫 유전자치료제 허가
http://www.etnews.com/20170905000218

[TV조선] 명의에게 듣는 한국 5대암
http://news.chosun.com/site/data/html_dir/2017/01/12/2017011203230.html

[건강한 당신] 폐암 환자의 ‘희망’ 3세대 표적치료제, 보험급여 이뤄져야
https://news.joins.com/article/20634587

[명의&인의를 찾아서-(75) 서울성모병원 피부암흑색종클리닉] 한국형 흑색종 연구 ‘새바람’
http://news.kmib.co.kr/article/view.asp?arcid=0923604277&code=14130000&cp=nv

“면역항암제, 간ㆍ뇌하수체 등에 염증 가능성”
http://www.hankookilbo.com/v/dfb8760f958c46d9a5d89518c388cc7c

강진형 교수, 대한항암요법연구회장에 선출
http://www.hankookilbo.com/v/1ac894d7e47c4241b909331316ff85d2

"'연구자주도 임상시험'은 반드시 가야할 길"
http://www.monews.co.kr/news/articleView.html?idxno=300276

포스팅

포스팅 내용이 없습니다.

영상자료

내 몸 사용 설명서 137회
http://vod.tvchosun.com/vod/3/C201400030/10666/vod.cstv

[내 몸 보고서] 국내 사망 1위 폐암…장기 생존 길 열렸다
https://science.ytn.co.kr/program/program_view.php?s_mcd=0082&s_hcd=0019&key=202105171648062101

[차클 마스터클라스] 음식 나눠 먹다가 위암 걸린다?!?? ′암에 안 걸리는 법′
https://www.youtube.com/watch?v=Jkh--ow3Dyk

발표자료

발표자료 내용이 없습니다.